Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
88284058 |
LAW OFFICE ASSIGNED |
LAW OFFICE 113 |
MARK SECTION |
MARK |
ORTIKOS (see, http://uspto.report/TM/88284058/mark.png) |
STANDARD CHARACTERS |
YES |
USPTO-GENERATED IMAGE |
YES |
LITERAL ELEMENT |
ORTIKOS |
OWNER SECTION (current) |
NAME |
Sun Pharma Global FZE |
INTERNAL ADDRESS |
704 Jumeirah Business Center 1 |
MAILING ADDRESS |
Cluster G, JLT, P.O. Box 643561 |
CITY |
Dubai |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United Arab Emirates |
EMAIL |
XXXX |
OWNER SECTION (proposed) |
NAME |
Sun Pharma Global FZE |
INTERNAL ADDRESS |
704 Jumeirah Business Center 1 |
MAILING ADDRESS |
Cluster G, JLT, P.O. Box 643561 |
CITY |
Dubai |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United Arab Emirates |
EMAIL |
XXXX |
CORRESPONDENCE INFORMATION (current) |
NAME |
CRAIG KUCHII, ESQ. |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
general.ip.mailbox@sunpharma.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
NOT PROVIDED |
CORRESPONDENCE INFORMATION (proposed) |
NAME |
Craig Kuchii, Esq. |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
general.ip.mailbox@sunpharma.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
christine.kenedy@sunpharma.com |
DOCKET/REFERENCE NUMBER |
SAETM-195US |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
005 |
CURRENT IDENTIFICATION |
Pharmaceutical preparations for the treatment and prevention of immune system related diseases and disorders; pharmaceutical preparations for
the treatment and prevention of gastrointestinal diseases, infections, conditions and/or problems |
GOODS OR SERVICES |
KEEP ALL LISTED |
EXTENSION SECTION |
EXTENSION NUMBER |
2 |
ONGOING EFFORT |
The applicant believes that it has made valid use of the mark in commerce, and is concurrently filing a Statement of Use (SOU), but that if the
USPTO finds the SOU to be fatally defective, the applicant will need additional time to file a new SOU. |
ALLOWANCE MAIL DATE |
07/23/2019 |
STATEMENT OF USE |
YES |
PAYMENT SECTION |
NUMBER OF CLASSES |
1 |
SUBTOTAL AMOUNT [EXTENSION FEE] |
125 |
TOTAL AMOUNT |
125 |
SIGNATURE SECTION |
SIGNATURE |
/craig kuchii/ |
SIGNATORY'S NAME |
Craig Kuchii |
SIGNATORY'S POSITION |
Associate Vice President, Intellectual Property |
DATE SIGNED |
07/22/2020 |
SIGNATORY'S PHONE NUMBER |
609-720-5394 |
FILING INFORMATION |
SUBMIT DATE |
Wed Jul 22 20:47:06 ET 2020 |
TEAS STAMP |
USPTO/ESU-XX.XXX.XXX.XXX-
20200722204706929812-8828
4058-740b48b1fa05eb418c7d
9d2db907675c96f7667f4c062
dd4a1963347c71643db80-DA-
47066264-2020072220424350
9412 |
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: ORTIKOS (see, http://uspto.report/TM/88284058/mark.png)
SERIAL NUMBER: 88284058
OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Sun Pharma Global FZE, having an address of
704 Jumeirah Business Center 1
Cluster G, JLT, P.O. Box 643561
Dubai,
United Arab Emirates
Email: XXXX
Proposed: Sun Pharma Global FZE, having an address of
704 Jumeirah Business Center 1
Cluster G, JLT, P.O. Box 643561
Dubai,
United Arab Emirates
Phone:
Fax:
Email: XXXX
The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application. The Notice of Allowance mailing date was 07/23/2019.
For International Class 005:
Current identification: Pharmaceutical preparations for the treatment and prevention of immune system related diseases and disorders; pharmaceutical preparations for the treatment and prevention of
gastrointestinal diseases, infections, conditions and/or problems
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
This is the second extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension
request: The applicant believes that it has made valid use of the mark in commerce, and is concurrently filing a Statement of Use (SOU), but that if the USPTO finds the SOU to be fatally defective,
the applicant will need additional time to file a new SOU.
A Statement of Use has already been submitted or is being submitted along with the Extension request as evidence that applicant believes that it has made valid use of the mark in commerce. If
the USPTO finds the Statement of Use to be fatally defective, the applicant requests additional time to file an amended or substitute Statement of Use.
Correspondence Information (current):
CRAIG KUCHII, ESQ.
PRIMARY EMAIL FOR CORRESPONDENCE: general.ip.mailbox@sunpharma.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED
Correspondence Information (proposed):
Craig Kuchii, Esq.
PRIMARY EMAIL FOR CORRESPONDENCE: general.ip.mailbox@sunpharma.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): christine.kenedy@sunpharma.com
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all
official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.
Declaration
STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section
1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the
mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of
the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near
resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.
DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and
the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made
on information and belief are believed to be true.
Signature: /craig kuchii/ Date Signed: 07/22/2020
Signatory's Name: Craig Kuchii
Signatory's Position: Associate Vice President, Intellectual Property
Signatory's Phone: 609-720-5394
RAM Sale Number: 88284058
RAM Accounting Date: 07/22/2020
Serial Number: 88284058
Internet Transmission Date: Wed Jul 22 20:47:06 ET 2020
TEAS Stamp: USPTO/ESU-XX.XXX.XXX.XXX-202007222047069
29812-88284058-740b48b1fa05eb418c7d9d2db
907675c96f7667f4c062dd4a1963347c71643db8
0-DA-47066264-20200722204243509412